# Leafline Labs, LLC: Form D filings

Leafline Labs, LLC, a pharmaceuticals company in Cottage Grove, MN, filed 3 Form D notices with the SEC between 2014 and 2016. The latest, on May 9, 2016, reports $149,600 sold of a $21 million offering to 1 investor.

Find out what Leafline Labs, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Leafline%20Labs%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Leafline%20Labs%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fleafline-labs-llc-1621013)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Leafline%20Labs%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Leafline%20Labs%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fleafline-labs-llc-1621013)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 8235 97th Street South, Cottage Grove, MN, 55016
- Phone: (844) 532-3546
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Minnesota
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1621013

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 9, 2016 | New notice | $21,000,000 | $149,600 | $20,850,400 | 1 | Jan 25, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1621013/000120919116118372/0001209191-16-118372-index.htm) |
| Oct 30, 2015 | Amendment | $15,125,000 | $14,948,643 | $176,357 | 141 | Dec 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1621013/000120919115077384/0001209191-15-077384-index.htm) |
| Dec 4, 2014 | New notice | $15,125,000 | $12,399,200 | $2,725,800 | 113 | Dec 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1621013/000118143114037869/0001181431-14-037869-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Gary Starr | Promoter |  |
| Peter Bachman | Promoter |  |
| Mark Bachman | Promoter |  |
| Paul Bachman | Promoter |  |
| Kelly Henry | Promoter |  |
| Glenn Taylor | Director, Promoter |  |
| Mitchell Baruchowitz | Director, Promoter |  |
| Andrew Bachman | Executive Officer, Director, Promoter |  |
| Ethan Ruby | Director, Promoter |  |
| Colin Kelley | Executive Officer |  |
| Tara Mulloy | Executive Officer |  |

[Every Form D from the week of May 9, 2016](https://specstream.ai/data/form-d/week/2016-05-09) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Leafline Labs, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).